Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Clevers

Showing results (381-390 of 688) with videos related to

Pageof 69
Sort By:
EMBO Reports|May 31, 2003
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vectorMarc van de Wetering, Irma Oving, Vanesa Muncan, et al.
The Journal of Cell Biology|March 9, 2011
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epitheliumFrançois Gerbe, Johan H van Es, Leila Makrini, et al.
Cancer Research|April 4, 2014
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwaysWim Verhaegh, Henk van Ooijen, Márcia A Inda, et al.
Cell|November 1, 2002
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinBEduard Batlle, Jeffrey T Henderson, Harry Beghtel, et al.
Cell Reports|May 7, 2020
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized MedicineKrijn K Dijkstra, Kim Monkhorst, Luuk J Schipper, et al.
Nature|June 17, 2005
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cellsJohan H van Es, Marielle E van Gijn, Orbicia Riccio, et al.
Nature Cancer|November 2, 2024
Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoidsTomohiro Mizutani, Matteo Boretto, Sangho Lim, et al.
Science Advances|February 26, 2025
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancerSeok-Young Kim, Tamar A E de Weert, Marijn Vermeulen, et al.
Disease Models & Mechanisms|January 16, 2010
Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibitionVivianda Menke, Johan H van Es, Wim de Lau, et al.
Nature|December 19, 2008
Crypt stem cells as the cells-of-origin of intestinal cancerNick Barker, Rachel A Ridgway, Johan H van Es, et al.
Pageof 69

Showing results (381-390 of 688) with videos related to

Sort By:
Pageof 69
EMBO Reports|May 31, 2003
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vectorMarc van de Wetering, Irma Oving, Vanesa Muncan, et al.
The Journal of Cell Biology|March 9, 2011
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epitheliumFrançois Gerbe, Johan H van Es, Leila Makrini, et al.
Cancer Research|April 4, 2014
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwaysWim Verhaegh, Henk van Ooijen, Márcia A Inda, et al.
Cell|November 1, 2002
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinBEduard Batlle, Jeffrey T Henderson, Harry Beghtel, et al.
Cell Reports|May 7, 2020
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized MedicineKrijn K Dijkstra, Kim Monkhorst, Luuk J Schipper, et al.
Nature|June 17, 2005
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cellsJohan H van Es, Marielle E van Gijn, Orbicia Riccio, et al.
Nature Cancer|November 2, 2024
Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoidsTomohiro Mizutani, Matteo Boretto, Sangho Lim, et al.
Science Advances|February 26, 2025
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancerSeok-Young Kim, Tamar A E de Weert, Marijn Vermeulen, et al.
Disease Models & Mechanisms|January 16, 2010
Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibitionVivianda Menke, Johan H van Es, Wim de Lau, et al.
Nature|December 19, 2008
Crypt stem cells as the cells-of-origin of intestinal cancerNick Barker, Rachel A Ridgway, Johan H van Es, et al.
Pageof 69